P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA

Detalles Bibliográficos
Autores principales: Xing, LI-Jie, Wei, Hai-Chen, Liu, Dan, Wang, Hui, LI, Ping, Xie, Lin-Na, LI, Zeng-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431168/
http://dx.doi.org/10.1097/01.HS9.0000971536.90361.c0
_version_ 1785091137207271424
author Xing, LI-Jie
Wei, Hai-Chen
Liu, Dan
Wang, Hui
LI, Ping
Xie, Lin-Na
LI, Zeng-Jun
author_facet Xing, LI-Jie
Wei, Hai-Chen
Liu, Dan
Wang, Hui
LI, Ping
Xie, Lin-Na
LI, Zeng-Jun
author_sort Xing, LI-Jie
collection PubMed
description
format Online
Article
Text
id pubmed-10431168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311682023-08-17 P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA Xing, LI-Jie Wei, Hai-Chen Liu, Dan Wang, Hui LI, Ping Xie, Lin-Na LI, Zeng-Jun Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431168/ http://dx.doi.org/10.1097/01.HS9.0000971536.90361.c0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Xing, LI-Jie
Wei, Hai-Chen
Liu, Dan
Wang, Hui
LI, Ping
Xie, Lin-Na
LI, Zeng-Jun
P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title_full P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title_fullStr P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title_full_unstemmed P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title_short P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
title_sort p1160: methotrexate in combination with ibrutinib, thiotepa, rituximab (r-mto) followed by autologous stem-cell transplant for primary cns lymphoma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431168/
http://dx.doi.org/10.1097/01.HS9.0000971536.90361.c0
work_keys_str_mv AT xinglijie p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT weihaichen p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT liudan p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT wanghui p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT liping p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT xielinna p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma
AT lizengjun p1160methotrexateincombinationwithibrutinibthioteparituximabrmtofollowedbyautologousstemcelltransplantforprimarycnslymphoma

Ejemplares similares